Novavax Inc.’s inventory soared Tuesday after the biotech firm reported optimistic outcomes from a trial of three flu and COVID vaccines and unveiled a restructuring that can see it half with 1 / 4 of its workers.
The transfer put the inventory on monitor for its largest one-day achieve in additional than two years as worries raised by the corporate’s “going-concern” warning from earlier this 12 months appeared to ease.
For…